In fact, the prevailing sentiment of AI and ML can be summarized by a line from a Forbes Technology Council article: “No matter how limited or simple the prior datasets, AI can come to a more accurate calculation and conclusion than a human mind.”
What is the real value-add of AI and ML for drug developers? Featured speakers from CAS, architect of the world’s largest human-curated scientific database, share the challenges and opportunities of artificial intelligence; what to keep in mind during the AI implementation journey; and its potential impact on drug discovery teams.
Join this webinar to learn about the strengths, limitations and impact of AI and ML techniques on drug discovery teams.
Join experts from CAS, Jeffrey Wilson, PhD, Data Science Manager; and Gary Gustafson, PhD, Senior Customer Success Specialist, for the live webinar on Tuesday, October 31, 2023, at 10am EDT (3pm CET/EU-Central).
For more information, or to register for this event, visit AI: Challenges, Opportunities and Impact for Drug Discovery Teams.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
